IGF::OT::IGF, R&D - VASCULAR INTERVENTION/INNOVATIONS THERAPEUTIC ADVANCES

血管干预/创新和治疗进展(VITA)计划是美国国家心肺血液研究所(NHLBI)的一项新的翻译计划，旨在支持和加速开发有前景的诊断和治疗模式，以满足未得到满足和服务不足的医疗需求。VITA计划为血管疾病、血栓性疾病和肺动脉高压领域的候选产品的早期翻译开发提供合同支持。

The Vascular Interventions/Innovations and Therapeutic Advances (VITA) Program is a new translational initiative of the National Heart, Lung, and Blood Institute (NHLBI) that enables and accelerates the development of promising diagnostic and therapeutic modalities for unmet and underserved medical needs. The VITA Program provides contract support for early-stage translational development of product candidates in the fields of vascular disorders, thrombotic diseases, and pulmonary hypertension.